60
Participants
Start Date
March 31, 2010
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Indibulin
Indibulin given orally once a day for 5 days followed by a 9 day rest
Memorial Sloan-Kettering Cancer Center, New York
The West Clinic, Memphis
Northwest Cancer Specialists, Vancouver
Evergreen Hematology Oncology, Spokane
Lead Sponsor
Memorial Sloan Kettering Cancer Center
OTHER
Alaunos Therapeutics
INDUSTRY